메뉴 건너뛰기




Volumn 39, Issue 1, 2003, Pages 98-105

Verapamil is associated with an increased risk of cancer in the elderly: The Rotterdam study

Author keywords

Adverse drug reactions; Antihypertensives; Calcium channel blockers; Cancer; Diltiazem; Nifedipine; Pharmaco epidemiology; Verapamil

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; VERAPAMIL;

EID: 0037215258     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00157-0     Document Type: Article
Times cited : (34)

References (31)
  • 1
    • 0000362047 scopus 로고    scopus 로고
    • Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
    • Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation the International Society of Hypertension Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J. Hypertens. 15:1997;105-115.
    • (1997) J. Hypertens. , vol.15 , pp. 105-115
  • 2
    • 0029132121 scopus 로고
    • Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
    • Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
    • (1995) Circulation , vol.92 , pp. 1326-1331
    • Furberg, C.D.1    Psaty, B.M.2    Meyer, J.V.3
  • 3
    • 0029873619 scopus 로고    scopus 로고
    • Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
    • Pahor M., Guralnik J.M., Furberg C.D., Carbonin P., Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 347:1996;1061-1065.
    • (1996) Lancet , vol.347 , pp. 1061-1065
    • Pahor, M.1    Guralnik, J.M.2    Furberg, C.D.3    Carbonin, P.4    Havlik, R.5
  • 4
    • 0030600342 scopus 로고    scopus 로고
    • Calcium-channel blockade and incidence of cancer in aged populations
    • Pahor M., Guralnik J.M., Ferrucci L.et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 348:1996;493-497.
    • (1996) Lancet , vol.348 , pp. 493-497
    • Pahor, M.1    Guralnik, J.M.2    Ferrucci, L.3
  • 6
    • 0030826328 scopus 로고    scopus 로고
    • Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
    • Fitzpatrick A.L., Daling J.R., Furberg C.D., Kronmal R.A., Weissfeld J.L. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer. 80:1997;1438-1447.
    • (1997) Cancer , vol.80 , pp. 1438-1447
    • Fitzpatrick, A.L.1    Daling, J.R.2    Furberg, C.D.3    Kronmal, R.A.4    Weissfeld, J.L.5
  • 7
    • 0030198951 scopus 로고    scopus 로고
    • Calcium channel blockers and cancer: Is an association biologically plausible?
    • Daling J.R. Calcium channel blockers and cancer. is an association biologically plausible? Am. J. Hypertens. 9:1996;713-714.
    • (1996) Am. J. Hypertens. , vol.9 , pp. 713-714
    • Daling, J.R.1
  • 8
    • 0029971675 scopus 로고    scopus 로고
    • Case-control study on colon cancer regarding previous diseases and drug intake
    • Hardell L.F.M., Axelson O. Case-control study on colon cancer regarding previous diseases and drug intake. Int. J. Oncol. 8:1996;439-444.
    • (1996) Int. J. Oncol. , vol.8 , pp. 439-444
    • Hardell, L.F.M.1    Axelson, O.2
  • 9
    • 0030965135 scopus 로고    scopus 로고
    • Cancer risk in users of calcium channel blockers
    • Olsen J.H., Toft Sorensen H.T., Friis S.et al. Cancer risk in users of calcium channel blockers. Hypertension. 29:1997;1091-1094.
    • (1997) Hypertension , vol.29 , pp. 1091-1094
    • Olsen, J.H.1    Toft Sorensen, H.T.2    Friis, S.3
  • 10
    • 0032054681 scopus 로고    scopus 로고
    • Calcium channel blockers and the risk of cancer
    • Rosenberg L., Rao R.S., Palmer J.R.et al. Calcium channel blockers and the risk of cancer. JAMA. 279:1998;1000-1004.
    • (1998) JAMA , vol.279 , pp. 1000-1004
    • Rosenberg, L.1    Rao, R.S.2    Palmer, J.R.3
  • 12
    • 0031747323 scopus 로고    scopus 로고
    • Nifedipine and cancer mortality: Ten-year follow-up of patients after acute myocardial infarction
    • Jonas M., Goldbourt U., Boyko V., Mandelzweig L., Behar S., Reicher Reiss H. Nifedipine and cancer mortality. ten-year follow-up of patients after acute myocardial infarction Cardiovasc Drugs Ther. 1998:2607;12. 177-181.
    • (1998) Cardiovasc Drugs Ther. , vol.2607 , Issue.12 , pp. 177-181
    • Jonas, M.1    Goldbourt, U.2    Boyko, V.3    Mandelzweig, L.4    Behar, S.5    Reicher Reiss, H.6
  • 14
    • 0032212372 scopus 로고    scopus 로고
    • Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: The Nurses' Health Study
    • Michels K.B., Rosner B.A., Walker A.M.et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: The Nurses' Health Study. Cancer. 83:1998;2003-2007.
    • (1998) Cancer , vol.83 , pp. 2003-2007
    • Michels, K.B.1    Rosner, B.A.2    Walker, A.M.3
  • 15
    • 0034645944 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
    • Meier C.R., Derby L.E., Jick S.S., Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch. Intern. Med. 160:2000;349-353.
    • (2000) Arch. Intern. Med. , vol.160 , pp. 349-353
    • Meier, C.R.1    Derby, L.E.2    Jick, S.S.3    Jick, H.4
  • 16
  • 18
    • 0029082271 scopus 로고
    • Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life
    • Herings R.M., Stricker B.H., de Boer A., Bakker A., Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch. Intern. Med. 155:1995;1801-1807.
    • (1995) Arch. Intern. Med. , vol.155 , pp. 1801-1807
    • Herings, R.M.1    Stricker, B.H.2    De Boer, A.3    Bakker, A.4    Sturmans, F.5
  • 20
    • 7344243229 scopus 로고    scopus 로고
    • Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux
    • Vaughan T.L., Farrow D.C., Hansten P.D.et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol. Biomarkers Prev. 7:1998;749-756.
    • (1998) Cancer Epidemiol. Biomarkers Prev. , vol.7 , pp. 749-756
    • Vaughan, T.L.1    Farrow, D.C.2    Hansten, P.D.3
  • 22
    • 0031877888 scopus 로고    scopus 로고
    • Treatment with calcium antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population: Results from STEPHY II. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly
    • Trenkwalder P., Hendricks P., Hense H.W. Treatment with calcium antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population. results from STEPHY II. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly J. Hypertens. 16:1998;1113-1116.
    • (1998) J. Hypertens. , vol.16 , pp. 1113-1116
    • Trenkwalder, P.1    Hendricks, P.2    Hense, H.W.3
  • 23
    • 0032521470 scopus 로고    scopus 로고
    • Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group
    • Braun S., Boyko V., Behar S.et al. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J. Am. Coll. Cardiol. 31:1998;804-808.
    • (1998) J. Am. Coll. Cardiol. , vol.31 , pp. 804-808
    • Braun, S.1    Boyko, V.2    Behar, S.3
  • 24
    • 0031915212 scopus 로고    scopus 로고
    • Cancer risk of hypertensive patients taking calcium antagonists
    • Hole D.J., Gillis C.R., McCallum I.R.et al. Cancer risk of hypertensive patients taking calcium antagonists. J. Hypertens. 16:1998;119-124.
    • (1998) J. Hypertens. , vol.16 , pp. 119-124
    • Hole, D.J.1    Gillis, C.R.2    McCallum, I.R.3
  • 25
    • 0033135919 scopus 로고    scopus 로고
    • Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial
    • (A9)
    • Sajadieh A., Storm H.H., Hansen J.F. Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial. Am. J. Cardiol. 83:1999;1419-1422. (A9).
    • (1999) Am. J. Cardiol. , vol.83 , pp. 1419-1422
    • Sajadieh, A.1    Storm, H.H.2    Hansen, J.F.3
  • 26
    • 0028059964 scopus 로고
    • Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators
    • Stewart B.W. Mechanisms of apoptosis. integration of genetic, biochemical, and cellular indicators J. Natl. Cancer Inst. 86:1994;1286-1296.
    • (1994) J. Natl. Cancer Inst. , vol.86 , pp. 1286-1296
    • Stewart, B.W.1
  • 27
    • 0026494066 scopus 로고
    • Calcium signals and cancer
    • Whitfield J.F. Calcium signals and cancer. Crit. Rev. Oncog. 3:1992;55-90.
    • (1992) Crit. Rev. Oncog. , vol.3 , pp. 55-90
    • Whitfield, J.F.1
  • 28
    • 0028946358 scopus 로고
    • Calcium-mediated cell injury and cell death
    • Trump B.F., Berezesky I.K. Calcium-mediated cell injury and cell death. Faseb. J. 9:1995;219-228.
    • (1995) Faseb. J. , vol.9 , pp. 219-228
    • Trump, B.F.1    Berezesky, I.K.2
  • 30
    • 0025007511 scopus 로고
    • Pharmacology of drugs that alter multidrug resistance in cancer
    • Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:1990;155-199.
    • (1990) Pharmacol. Rev. , vol.42 , pp. 155-199
    • Ford, J.M.1    Hait, W.N.2
  • 31
    • 0029939665 scopus 로고    scopus 로고
    • Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers
    • Ford J.M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer. 32A:1996;991-1001.
    • (1996) Eur. J. Cancer , vol.32 A , pp. 991-1001
    • Ford, J.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.